A20S (p.Ala20Ser) variant of MYL3 (Myosin light chain 3)

A20S (p.Ala20Ser) in MYL3 (Myosin light chain 3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hypertrophic cardiomyopathy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.42 / 1. The record also includes population frequency data and structural context.

A20S (p.Ala20Ser) variant details